197 related articles for article (PubMed ID: 29850140)
1. Cardiac radiation dose distribution, cardiac events and mortality in early-stage lung cancer treated with stereotactic body radiation therapy (SBRT).
Reshko LB; Kalman NS; Hugo GD; Weiss E
J Thorac Dis; 2018 Apr; 10(4):2346-2356. PubMed ID: 29850140
[TBL] [Abstract][Full Text] [Related]
2. Cardiac Dose and Survival After Stereotactic Body Radiotherapy for Early-stage Non-Small-cell Lung Cancer.
Tembhekar AR; Wright CL; Daly ME
Clin Lung Cancer; 2017 May; 18(3):293-298. PubMed ID: 28089158
[TBL] [Abstract][Full Text] [Related]
3. Is mean heart dose a relevant surrogate parameter of left ventricle and coronary arteries exposure during breast cancer radiotherapy: a dosimetric evaluation based on individually-determined radiation dose (BACCARAT study).
Jacob S; Camilleri J; Derreumaux S; Walker V; Lairez O; Lapeyre M; Bruguière E; Pathak A; Bernier MO; Laurier D; Ferrieres J; Gallocher O; Latorzeff I; Pinel B; Franck D; Chevelle C; Jimenez G; Broggio D
Radiat Oncol; 2019 Feb; 14(1):29. PubMed ID: 30732640
[TBL] [Abstract][Full Text] [Related]
4. Association of Left Anterior Descending Coronary Artery Radiation Dose With Major Adverse Cardiac Events and Mortality in Patients With Non-Small Cell Lung Cancer.
Atkins KM; Chaunzwa TL; Lamba N; Bitterman DS; Rawal B; Bredfeldt J; Williams CL; Kozono DE; Baldini EH; Nohria A; Hoffmann U; Aerts HJWL; Mak RH
JAMA Oncol; 2021 Feb; 7(2):206-219. PubMed ID: 33331883
[TBL] [Abstract][Full Text] [Related]
5. Cardiac substructures exposure in left-sided breast cancer radiotherapy: Is the mean heart dose a reliable predictor of cardiac toxicity?
Naimi Z; Moujahed R; Neji H; Yahyaoui J; Hamdoun A; Bohli M; Kochbati L
Cancer Radiother; 2021 May; 25(3):229-236. PubMed ID: 33423965
[TBL] [Abstract][Full Text] [Related]
6. Impact of Cardiac Dose on Overall Survival in Lung Stereotactic Body Radiotherapy (SBRT) Compared to Conventionally Fractionated Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC).
Anderson JD; Hu J; Li J; Schild SE; Fatyga M
J Cancer Ther; 2021 Jul; 12(7):409-423. PubMed ID: 34367717
[TBL] [Abstract][Full Text] [Related]
7. Survival Impact of Cardiac Dose Following Lung Stereotactic Body Radiotherapy.
Wong OY; Yau V; Kang J; Glick D; Lindsay P; Le LW; Sun A; Bezjak A; Cho BCJ; Hope A; Giuliani M
Clin Lung Cancer; 2018 Mar; 19(2):e241-e246. PubMed ID: 28941961
[TBL] [Abstract][Full Text] [Related]
8. Mean Heart Dose Is an Inadequate Surrogate for Left Anterior Descending Coronary Artery Dose and the Risk of Major Adverse Cardiac Events in Lung Cancer Radiation Therapy.
Atkins KM; Bitterman DS; Chaunzwa TL; Kozono DE; Baldini EH; Aerts HJWL; Tamarappoo BK; Hoffmann U; Nohria A; Mak RH
Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1473-1479. PubMed ID: 33713743
[TBL] [Abstract][Full Text] [Related]
9. Vertebral compression fractures after stereotactic body radiation therapy: a large, multi-institutional, multinational evaluation.
Jawad MS; Fahim DK; Gerszten PC; Flickinger JC; Sahgal A; Grills IS; Sheehan J; Kersh R; Shin J; Oh K; Mantel F; Guckenberger M;
J Neurosurg Spine; 2016 Jun; 24(6):928-36. PubMed ID: 26895526
[TBL] [Abstract][Full Text] [Related]
10. Dose to heart substructures is associated with non-cancer death after SBRT in stage I-II NSCLC patients.
Stam B; Peulen H; Guckenberger M; Mantel F; Hope A; Werner-Wasik M; Belderbos J; Grills I; O'Connell N; Sonke JJ
Radiother Oncol; 2017 Jun; 123(3):370-375. PubMed ID: 28476219
[TBL] [Abstract][Full Text] [Related]
11. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
[TBL] [Abstract][Full Text] [Related]
12. Assessing radiation exposure of the left anterior descending artery, heart and lung in patients with left breast cancer: A dosimetric comparison between multicatheter accelerated partial breast irradiation and whole breast external beam radiotherapy.
Chan TY; Tan PW; Tan CW; Tang JI
Radiother Oncol; 2015 Dec; 117(3):459-66. PubMed ID: 26328940
[TBL] [Abstract][Full Text] [Related]
13. A matched-pair analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lung tumors from colorectal cancer versus early stage non-small cell lung cancer.
Wang X; Zamdborg L; Ye H; Grills IS; Yan D
BMC Cancer; 2018 Oct; 18(1):962. PubMed ID: 30305131
[TBL] [Abstract][Full Text] [Related]
14. The Impact of Radiation Dose to Heart Substructures on Major Coronary Events and Patient Survival after Chemoradiation Therapy for Esophageal Cancer.
Wang X; Palaskas NL; Hobbs BP; Abe JI; Nead KT; Yusuf SW; Hermann J; Deswal A; Lin SH
Cancers (Basel); 2022 Mar; 14(5):. PubMed ID: 35267613
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic body radiotherapy for central lung tumors.
Rowe BP; Boffa DJ; Wilson LD; Kim AW; Detterbeck FC; Decker RH
J Thorac Oncol; 2012 Sep; 7(9):1394-9. PubMed ID: 22843088
[TBL] [Abstract][Full Text] [Related]
16. Feasibility study of stereotactic body radiotherapy for peripheral lung tumors with a maximum dose of 100 Gy in five fractions and a heterogeneous dose distribution in the planning target volume.
Takeda A; Oku Y; Sanuki N; Eriguchi T; Aoki Y; Enomoto T; Kaneko T; Nishimura S; Kunieda E
J Radiat Res; 2014 Sep; 55(5):988-95. PubMed ID: 24833770
[TBL] [Abstract][Full Text] [Related]
17. Spatial and dose-response analysis of fibrotic lung changes after stereotactic body radiation therapy.
Vinogradskiy Y; Diot Q; Kavanagh B; Schefter T; Gaspar L; Miften M
Med Phys; 2013 Aug; 40(8):081712. PubMed ID: 23927309
[TBL] [Abstract][Full Text] [Related]
18. Tumor Control and Toxicity for Common Stereotactic Body Radiation Therapy Dose-Fractionation Regimens in Stage I Non-Small Cell Lung Cancer.
Stephans KL; Woody NM; Reddy CA; Varley M; Magnelli A; Zhuang T; Qi P; Videtic GMM
Int J Radiat Oncol Biol Phys; 2018 Feb; 100(2):462-469. PubMed ID: 29353658
[TBL] [Abstract][Full Text] [Related]
19. Stereotactic body radiation therapy (SBRT) for lung malignancies: preliminary toxicity results using a flattening filter-free linear accelerator operating at 2400 monitor units per minute.
Prendergast BM; Dobelbower MC; Bonner JA; Popple RA; Baden CJ; Minnich DJ; Cerfolio RJ; Spencer SA; Fiveash JB
Radiat Oncol; 2013 Nov; 8():273. PubMed ID: 24256563
[TBL] [Abstract][Full Text] [Related]
20. Concomitant Chemotherapy and Radiotherapy with SBRT Boost for Unresectable Stage III Non-Small Cell Lung Cancer: A Phase I Study.
Higgins KA; Pillai RN; Chen Z; Tian S; Zhang C; Patel P; Pakkala S; Shelton J; Force SD; Fernandez FG; Steuer CE; Owonikoko TK; Ramalingam SS; Bradley JD; Curran WJ
J Thorac Oncol; 2017 Nov; 12(11):1687-1695. PubMed ID: 28919394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]